Catalent Applied Drug Delivery Institute Appoints New Advisory Board Member - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Catalent Applied Drug Delivery Institute Appoints New Advisory Board Member



The Catalent Applied Drug Delivery Institute, an institute formed by Catalent Pharma Solutions, to promote collaboration between industry and academia, provide applied drug-delivery education and training, and advanced drug delivery, has appointed Claus-Michael Lehr, Head of the Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, Germany and Co-founder and Head of the Department “Drug Delivery” of the Helmholtz Institute for Pharmaceutical Research Saarlandto the institute’s advisory board.

Professor Lehr has t more than 15 years researching ways to overcome biological barriers to effective drug delivery and the development and formulation of appropriate carriers to transport active pharmaceutical and biopharmaceutical molecules to desired targets. He has co-authored many publications on the development of sophisticated in-vitro models that represent the epithelial cells and tissues concerned in transport, and the application of nanotechnology to improve in-vivo delivery to such therapeutic targets.

Source: Catalent

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
26%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here